Profusa (NVACW) Receivables - Other (2021 - 2022)

Profusa (NVACW) reported Receivables - Other of $25000.0 for Q1 2022, little changed quarter-over-quarter from $25000.0 in Q4 2021.

Profusa (NVACW) Receivables - Other (2021 - 2022) Analysis & Trends

Profusa has reported Receivables - Other for 2 years, with the latest figure at $25000.0 in Q1 2022.

For the quarter ending Q1 2022, Receivables - Other changed N/A year-over-year to $25000.0; the trailing twelve-month figure through Mar 2022 stood at $25000.0 (changed N/A YoY), and the FY2021 full-year result was $25000.0, changed N/A from the prior year.
Receivables - Other for Q1 2022 stood at $25000.0, roughly flat from $25000.0 in the prior quarter.
The five-year high for Receivables - Other was $25000.0 in Q4 2021, with the low at $25000.0 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Profusa	-	-	-

Download Data